Distinctive Autophagy/mitophagy Biomarker Profiles in Frontotemporal Lobar Degeneration and Alzheimer's Disease

Overview

Journal Acta Neuropathol Commun

Publisher Biomed Central

Specialty Neurology

Date 2025 Feb 19

PMID 39972393

Authors

Katerina Veverova

Alzbeta Katonova

Hana Horakova

Jan Laczo

Francesco Angelucci

Jakub Hort

Sofie Lautrup

Evandro Fei Fang

Martin Vyhnalek

Affiliations

Soon will be listed here.

Abstract

Maintaining cellular homeostasis by removing damaged and senescent mitochondria, a process termed mitophagy, is crucial in preventing Alzheimer's disease (AD) and represents a promising therapeutic target. Our previous research revealed altered mitophagy biomarkers, such as increased CSF and serum PINK1 and serum BNIP3L and decreased serum TFEB levels, indicating impaired autophagy-lysosomal degradation in the AD continuum. However, the role of autophagy/mitophagy in frontotemporal lobar degeneration (FTLD) remains unclear. This study investigated the biomarkers of autophagy/mitophagy and lysosomal biogenesis (PINK1, ULK1, BNIP3L, and TFEB) in biofluids (CSF and serum) from 308 biomarker-defined individuals across the FTLD continuum (FTLD-dementia, n = 29; FTLD-MCI, n = 33) and compared them with those across the AD continuum (MCI-AD, n = 100; AD-dementia, n = 100) and cognitively unimpaired (CU) controls (n = 46) recruited from Czech Brain Aging Study. Additionally, we compared the mitophagy biomarkers across different FTLD clinical subtypes (frontal, semantic and nonfluent variant) with CU, and explored the association between mitophagy biomarkers and clinical phenotypes of FTLD (biomarkers of tau, biomarkers of neurodegeneration, cognition and ATN profile).Our findings indicated a significantly lower CSF PINK1 and ULK1 levels in FTLD compared to AD, with FTLD dementia showing particularly low CSF PINK1 levels compared to AD-dementia. Conversely, CSF ULK1 levels were higher in FTLD-MCI compared to AD-dementia. Serum analyses revealed lower PINK1 and higher TFEB levels in FTLD dementia compared to AD dementia. This study provides compelling evidence of distinct alterations in autophagy/mitophagy biomarkers between FTLD and AD, indicating that these neurodegenerative diseases may affect the cellular waste disposal system through different pathways. This is the first study to explore mitophagy biomarkers in human CSF and serum in FTLD, opening avenues for further research and potential clinical applications.

References

Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

Nikolai T, Stepankova H, Kopecek M, Sulc Z, Vyhnalek M, Bezdicek O . The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective. J Alzheimers Dis. 2018; 61(3):1233-1240. PMC: 6939612. DOI: 10.3233/JAD-170595. View

Fang E, Hou Y, Palikaras K, Adriaanse B, Kerr J, Yang B . Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci. 2019; 22(3):401-412. PMC: 6693625. DOI: 10.1038/s41593-018-0332-9. View

Rodriguez-Perinan G, de la Encarnacion A, Moreno F, de Munain A, Martinez A, Martin-Requero A . Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions. Antioxidants (Basel). 2023; 12(3). PMC: 10044829. DOI: 10.3390/antiox12030581. View

Veverova K, Laczo J, Katonova A, Horakova H, Matuskova V, Angelucci F . Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease. Autophagy. 2024; 20(8):1868-1878. PMC: 11262225. DOI: 10.1080/15548627.2024.2340408. View

Zachari M, Ganley I . The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017; 61(6):585-596. PMC: 5869855. DOI: 10.1042/EBC20170021. View

Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat D . Automatically parcellating the human cerebral cortex. Cereb Cortex. 2003; 14(1):11-22. DOI: 10.1093/cercor/bhg087. View

Voevodskaya O, Simmons A, Nordenskjold R, Kullberg J, Ahlstrom H, Lind L . The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease. Front Aging Neurosci. 2014; 6:264. PMC: 4188138. DOI: 10.3389/fnagi.2014.00264. View

10.

Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H . Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019; 90(8):870-881. DOI: 10.1136/jnnp-2018-320106. View

11.

Fischl B, Salat D, Busa E, Albert M, Dieterich M, Haselgrove C . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002; 33(3):341-55. DOI: 10.1016/s0896-6273(02)00569-x. View

12.

Antonioni A, Raho E, Lopriore P, Pace A, Latino R, Assogna M . Frontotemporal Dementia, Where Do We Stand? A Narrative Review. Int J Mol Sci. 2023; 24(14). PMC: 10380352. DOI: 10.3390/ijms241411732. View

13.

Ugolino J, Ji Y, Conchina K, Chu J, Nirujogi R, Pandey A . Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling. PLoS Genet. 2016; 12(11):e1006443. PMC: 5119725. DOI: 10.1371/journal.pgen.1006443. View

14.

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein H, Vermersch P . Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992; 55(10):967-72. PMC: 1015202. DOI: 10.1136/jnnp.55.10.967. View

15.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

16.

Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R . A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016; 2(9):e1601167. PMC: 5010369. DOI: 10.1126/sciadv.1601167. View

17.

Sun X, Duan Y, Qin C, Li J, Duan G, Deng X . Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018; 9(10):953. PMC: 6148241. DOI: 10.1038/s41419-018-1022-y. View

18.

Gobom J, Parnetti L, Rosa-Neto P, Vyhnalek M, Gauthier S, Cataldi S . Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med. 2021; 60(2):207-219. DOI: 10.1515/cclm-2021-0651. View

19.

Petersen R . Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3):183-94. DOI: 10.1111/j.1365-2796.2004.01388.x. View

20.

Nixon R, Wegiel J, Kumar A, Yu W, Peterhoff C, Cataldo A . Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005; 64(2):113-22. DOI: 10.1093/jnen/64.2.113. View